Menu

去纤维钠医保能否报销?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

(Defitelio) is a biochemical drug derived from a mixture of single-chain deoxyoligonucleotides. It mainly acts on endothelial cells and produces a variety of biological effects. Clinical research is mainly carried out around the indications of cardiovascular dysfunction. Clinical experiments have confirmed that defitelio can effectively prevent and treat hepatic veno-occlusive disease.

Using defibrinated sodium to treat hepatic veno-occlusive disease can inhibit the occurrence of apoptosis of vascular endothelial cells, inhibit immune effector cells from entering tissues through endothelial cells, and reduce the occurrence of inflammatory damage. Defibrotide sodium (defibrotide) has been shown to downregulate the expression of cell adhesion molecules CAMs, which are related to inflammatory responses and hematopoietic stem cell mobilization. There are many new blood vessels around the tumor tissue, and defibrinated sodium has anti-neovascularization effect, which is considered to be the basis of its anti-tumor effect.

Defibrotide sodium (defibrotide) was first approved for marketing by the EU EMA on October 18, 2013, and received orphan drug designation. On March 30, 2016, the drug was officially approved by the US FDA. So, can defibrinated sodium be reimbursed by medical insurance?

The answer is no. Because defibrinated sodium is not currently on the market in China, and has not been included in the national medical insurance directory, patients will not be able to enjoy the benefits brought by medical insurance in the short term. However, I believe that with the joint efforts and promotion of all parties, defibrinated sodium will be launched in China as soon as possible and will be covered by medical insurance.

According to Medical Travel, the original drug is priced at 21,600$/box in foreign countries, and the specification is 200mg/box. Although this price is expensive, based on the actual situation of the current market, there are not many purchasing channels for patients to choose from, so patients can choose based on their own needs when making actual purchases. In order to obtain the medicines they need more conveniently, patients can contact Medical Companion Travel to purchase them.

Recommended hot articles: /newsDetail/78712.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。